KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Shares Issued (2016 - 2025)

Exact Sciences (EXAS) has disclosed Shares Issued for 16 consecutive years, with $10.5 million as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 11.11% to $10.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.3 million through Dec 2025, up 1789.56% year-over-year, with the annual reading at $26.5 million for FY2025, 15.0% down from the prior year.
  • Shares Issued for Q4 2025 was $10.5 million at Exact Sciences, down from $11.8 million in the prior quarter.
  • The five-year high for Shares Issued was $15.4 million in Q2 2023, with the low at -$13.1 million in Q4 2023.
  • Average Shares Issued over 5 years is $3.6 million, with a median of $3.3 million recorded in 2021.
  • The sharpest move saw Shares Issued plummeted 945.54% in 2022, then soared 1969.99% in 2023.
  • Over 5 years, Shares Issued stood at $1.1 million in 2021, then tumbled by 945.54% to -$9.0 million in 2022, then crashed by 46.0% to -$13.1 million in 2023, then skyrocketed by 189.94% to $11.8 million in 2024, then fell by 11.11% to $10.5 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $10.5 million, $11.8 million, and -$13.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.